This is seen in the fact that the monospecific FAP-IL accumulated and was activated much slower in both tumor models as compared to the Bi-FAP/HER2-IL, and revealed continuous fluorescence increases of HT1080-hFAP up to 48 h post-injection (Figure 7A,B, FAP-IL). This evidence concerns the gene ERBB2 and neoplasm.